UBS Group’s Aterian ATER Stock Holding History
Bought
Maintained
Sold
Other funds holding ATER
XT
VCM
VFT
UBS Group's ATER Position: Q1 2026 in Review
UBS Group reduced its Aterian (ATER) stake by 8.3% in Q1 2026, selling an estimated $326 and leaving 5,499 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #9133.
UBS Group first reported a position in ATER in Q2 2019 and has held it in 27 quarters since. The position peaked at $252K in Q4 2021. 26 funds tracked by Wall St. Rank hold ATER as of Q1 2026.
- UBS Group held 5,499 shares of Aterian worth $3.15K as of Q1 2026.
- UBS Group sold 498 Aterian shares in Q1 2026, an estimated $326.
- Aterian made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9133 holding.
- UBS Group first reported a position in Aterian in Q2 2019 and has held it in 27 quarters since.
- UBS Group's Aterian position peaked at $252K in Q4 2021.
- 26 funds tracked by Wall St. Rank held Aterian as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.